Cerebellar manifestation of PML under fumarate and after efalizumab treatment of psoriasis

Journal of Neurology

Volumn 261, Issue 5, 2014, Pages 1021-1024

  Stoppe, Muriel ^a   Thomä, Eva ^a   Liebert, Uwe Gerd ^a   Major, Eugene O ^b   Hoffmann, Karl Titus ^a   Claßen, Joseph ^a   Then Bergh, Florian ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFALIZUMAB; FUMADERM; FUMARIC ACID; FUMARIC ACID DERIVATIVE; FUMARIC ACID DIMETHYL ESTER; MONOCLONAL ANTIBODY;

CASE REPORT; CEREBELLAR PEDUNCLE; CEREBELLUM; CEREBROSPINAL FLUID ANALYSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; JC VIRUS; LETTER; LYMPHOCYTOPENIA; MALE; POLYMERASE CHAIN REACTION; PONS; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PSORIASIS; CHEMICALLY INDUCED; DRUG EFFECTS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; PATHOLOGY; TREATMENT OUTCOME; VIROLOGY;

ANTIBODIES, MONOCLONAL; CEREBELLUM; FUMARATES; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; PSORIASIS; TREATMENT OUTCOME;

EID: 84901927582     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-014-7311-1     Document Type: Letter

References (11)

1. Ermis U, Weis J, Schulz JB (2013) PML in a patient treated with fumaric acid. N Engl J Med 368:1657-1658
2. Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, Dawson KT (2012) Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 367:1098-1107
3. Koralnik IJ, Wuthrich C, Dang X, Rottnek M, Gurtman A, Simpson D, Morgello S (2005) JC virus granule cell neuronopathy: a novel clinical syndrome distinct from progressive multifocal leukoencephalopathy. Ann Neurol 57:576-580 (Pubitemid 40471172)
4. Kothary N, Diak IL, Brinker A, Bezabeh S, Avigan M, Dal Pan G (2011) Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients. J Am Acad Dermatol 65:546-551
5. Moenster RP, Jett RA (2012) Mirtazapine and mefloquine therapy for progressive multifocal leukoencephalopathy in a patient infected with human immunodeficiency virus. Am J Health Syst Pharm 69:496-498
6. Ryschkewitsch CF, Jensen PN, Major EO (2013) Multiplex qPCR assay for ultra sensitive detection of JCV DNA with simultaneous identification of genotypes that discriminates non-virulent from virulent variants. J Clin Virol 57:243-248
7. Sorensen PS, Bertolotto A, Edan G, Giovannoni G, Gold R, Havrdova E, Kappos L, Kieseier BC, Montalban X, Olsson T (2012) Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab. Mult Scler 18:143-152
8. Sweetser MT, Dawson KT, Bozic C (2013) Manufacturer's response to case reports of PML. N Engl J Med 368:1659-1661
9. van Oosten BW, Killestein J, Barkhof F, Polman CH, Wattjes MP (2013) PML in a patient treated with dimethyl fumarate from a compounding pharmacy. N Engl J Med 368:1658-1659
10. Wattjes MP, Richert ND, Killestein J, de Vos M, Sanchez E, Snaebjornsson P, Cadavid D, Barkhof F (2013) The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy. Mult Scler 19:1826-1840
11. Wuthrich C, Dang X, Westmoreland S, McKay J, Maheshwari A, Anderson MP, Ropper AH, Viscidi RP, Koralnik IJ (2009) Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons. Ann Neurol 65:742-748